Enhanced apoptosis and mitochondrial cell death by paclitaxel-loaded TPP-TPGS1000-functionalized nanoemulsion.
暂无分享,去创建一个
S. Rath | M. K. Chourasia | J. Gayen | K. Mitra | M. Wahajuddin | Saurabh Verma | Navodayam Kalleti | M. Mugale | Ravi Saklani | Keerti Mishra | Rafquat Rana | Ashwini S Kedar | Amrendra K Tiwari | Divya Chauhan | D. Sharma | P. Yadav | Pooja Yadav | R. Saklani | P. Yadav
[1] U. Murty,et al. Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction. , 2021, European journal of pharmacology.
[2] M. K. Chourasia,et al. Paclitaxel-Loaded Colloidal Silica and TPGS-Based Solid Self-Emulsifying System Interferes Akt/mTOR Pathway in MDA-MB-231 and Demonstrates Anti-tumor Effect in Syngeneic Mammary Tumors , 2020, AAPS PharmSciTech.
[3] V. Rotello,et al. Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies , 2020, International journal of environmental research and public health.
[4] M. Kamal,et al. NANOMEDICINE IN TREATMENT OF BREAST CANCER - A CHALLENGE TO CONVENTIONAL THERAPY. , 2019, Seminars in cancer biology.
[5] S. Rath,et al. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate. , 2019, Molecular pharmaceutics.
[6] Manishita R. Sharma,et al. Paclitaxel-loaded TPGS enriched self-emulsifying carrier causes apoptosis by modulating survivin expression and inhibits tumour growth in syngeneic mammary tumours , 2018, Artificial cells, nanomedicine, and biotechnology.
[7] S. Rath,et al. Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site , 2018, Advanced healthcare materials.
[8] M. Shibutani,et al. Fluorescence tumor imaging by i.v. administered indocyanine green in a mouse model of colitis‐associated colon cancer , 2018, Cancer science.
[9] Dan Peer,et al. Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.
[10] James R. Smith,et al. Liposomal Drug Delivery Systems and Anticancer Drugs , 2018, Molecules.
[11] G. Canto,et al. Carbon Nanomaterials for Breast Cancer Treatment , 2018 .
[12] Yujie Zhang,et al. Overcoming Multidrug Resistance through the GLUT1-Mediated and Enzyme-Triggered Mitochondrial Targeting Conjugate with Redox-Sensitive Paclitaxel Release. , 2018, ACS applied materials & interfaces.
[13] M. Aqil,et al. Ultrasonically tailored, chemically engineered and "QbD" enabled fabrication of agomelatine nanoemulsion; optimization, characterization, ex-vivo permeation and stability study. , 2018, Ultrasonics sonochemistry.
[14] Jianqing Gao,et al. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies. , 2018, Molecular pharmaceutics.
[15] Mengjiao Zhou,et al. Mitochondrial-Targeting Lonidamine-Doxorubicin Nanoparticles for Synergistic Chemotherapy to Conquer Drug Resistance. , 2017, ACS applied materials & interfaces.
[16] Manisha Pandey,et al. Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. , 2017, International journal of pharmaceutics.
[17] Jing Chen,et al. Trackable Mitochondria-Targeting Nanomicellar Loaded with Doxorubicin for Overcoming Drug Resistance. , 2017, ACS applied materials & interfaces.
[18] S. Rath,et al. Click Biotinylation of PLGA Template for Biotin Receptor Oriented Delivery of Doxorubicin Hydrochloride in 4T1 Cell-Induced Breast Cancer. , 2017, Molecular pharmaceutics.
[19] Shweta Sharma,et al. P-gp modulatory acetyl-11-keto-β-boswellic acid based nanoemulsified carrier system for augmented oral chemotherapy of docetaxel. , 2017, Colloids and surfaces. B, Biointerfaces.
[20] J. Joseph,et al. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. , 2017, Chemical reviews.
[21] Yan-fang Yang,et al. Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of Low-Dose Paclitaxel by Driving Th1 Immune Response , 2017, Pharmaceutical Research.
[22] Young-Joon Park,et al. High paclitaxel-loaded and tumor cell-targeting hyaluronan-coated nanoemulsions. , 2017, Colloids and surfaces. B, Biointerfaces.
[23] Xueqin Gao,et al. Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy , 2017, Drug delivery.
[24] K. Al‐Jamal,et al. Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice In Vivo , 2017, Nanotheranostics.
[25] Peter A. Williams,et al. Influence of OSA-starch on the physico chemical characteristics of flax seed oil-eugenol nanoemulsions , 2016 .
[26] R. Konwar,et al. Vitamin B6 Tethered Endosomal pH Responsive Lipid Nanoparticles for Triggered Intracellular Release of Doxorubicin. , 2016, ACS applied materials & interfaces.
[27] M. Shibutani,et al. Preferential tumor cellular uptake and retention of indocyanine green for in vivo tumor imaging , 2016, International journal of cancer.
[28] T. Choudhuri,et al. Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell line , 2016, Journal of Biomedical Science.
[29] P. Singh,et al. Synergistic Chemotherapeutic Activity of Curcumin Bearing Methoxypolyethylene Glycol-g-Linoleic Acid Based Micelles on Breast Cancer Cells. , 2016, Journal of nanoscience and nanotechnology.
[30] Shweta Sharma,et al. Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth. , 2015, Acta biomaterialia.
[31] P. Singh,et al. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment. , 2015, Journal of biomedical nanotechnology.
[32] P. R. Sharma,et al. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine. , 2015, International journal of pharmaceutics.
[33] J. Modica-Napolitano,et al. Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents , 2015, International journal of molecular sciences.
[34] Q. Zhong,et al. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers. , 2015, Molecular pharmaceutics.
[35] P. Morais,et al. Mitochondria-targeting nanoplatform with fluorescent carbon dots for long time imaging and magnetic field-enhanced cellular uptake. , 2015, ACS applied materials & interfaces.
[36] M. K. Chourasia,et al. Reinvestigating nanoprecipitation via Box–Behnken design: a systematic approach , 2015, Journal of microencapsulation.
[37] P. Singh,et al. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[38] S. Jain,et al. Paclitaxel formulations: challenges and novel delivery options. , 2014, Current drug delivery.
[39] V. Préat,et al. Vitamin E-based nanomedicines for anti-cancer drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[40] P. Papageorgis,et al. D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells. , 2014, Biochemical pharmacology.
[41] R. Lu,et al. Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging , 2013, PloS one.
[42] Nan Li,et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. , 2013, Biomaterials.
[43] S. Satyanarayanajois,et al. Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[44] Chee Wee Gan,et al. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. , 2010, Biomaterials.
[45] Fuzheng Ren,et al. Synthesis and Characterization of D-α-Tocopheryl Polyethylene Glycol 1000 Succinate-Block-Poly (ϵ-caprolactone) Copolymer Used as Carriers for Microparticles , 2009 .
[46] Xiaoling Fang,et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. , 2009, International journal of pharmaceutics.
[47] H. Harashima,et al. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. , 2008, Advanced drug delivery reviews.
[48] J. Kopeček,et al. Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting. , 2008, Molecular pharmaceutics.
[49] Jie Pan,et al. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. , 2008, Biomaterials.
[50] W. Davros,et al. Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots. , 2008, Nanomedicine.
[51] R. Kappl,et al. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. , 2007, Molecular pharmaceutics.
[52] S. Gaisford,et al. Diode-array UV spectrometric evidence for cooperative interactions in binary mixtures of Pluronics F77, F87, and F127 , 1997 .